Prevalence of perinuclear Antineutrophil cytoplasmic antibody in patients with graves' disease treated with propylthiouracil or methimazole in Taiwan

Journal of the Formosan Medical Association

Volumn 103, Issue 4, 2004, Pages 274-279

  Huang, Chien Ning ^a   Hsu, Tsai Ching ^a   Chou, Hsi Hsien ^a   Tsay, Gregory J ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA); Graves' disease; Methimazole; Propylthiouracil; Vasculitis

Indexed keywords

MICROSOME ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN RECEPTOR; ANTITHYROID AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ERUPTION; ECCHYMOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLU LIKE SYNDROME; GRAVES DISEASE; HUMAN; IMMUNOFLUORESCENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; PASSIVE HEMAGGLUTINATION; PREVALENCE; RADIORECEPTOR ASSAY; SEX DIFFERENCE; TAIWAN; THROMBOCYTOPENIA; BLOOD; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MIDDLE AGED; PREVALENCE; PROPYLTHIOURACIL; TAIWAN;

EID: 3342887120     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hoffman GS, Specks U: Anti-neutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.
2. Gross WL, Schmitt WH, Csernok E: ANCA and associated disease: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1-12.
3. Fu HL, Hsu TC, Chang CC, et al: Antigenic specificity of anti-neutrophil cytoplasmic antibody. J Formos Med Assoc 2001; 100:35-9.
4. Van der Wounde FJ, Rasmussen N, Lobatto S, et al: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i: 425-9.
5. Falk RJ, Jenette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
6. Cooper DS: Antithyroid drugs. N Engl J Med 1984;311:1353-62.
7. Stankus SJ, Johnson NT: Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992;120:1595-6.
8. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and anti-neutrophil cytoplasmic antibodies associated with propyl-thiouracil therapy. Lancet 1993;342:651-2.
9. Tanemoto M, Miyakawa H, Hania J, et al: Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Grave's disease: report of the three adult cases. Am J Kidney Dis 1995;26:774-80.
10. Kitahara T, Hiromura K, Maezawa A, et al: Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA): review of literature. Clin Nephrol 1997;47 336-40.
11. Fujii A, Arimura Y, Minoshima S, et al: MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy [in Japanese; English abstract]. Ryumachi 1997 37:788-93.
12. Ohtsuka M, Yamashita Y, Doi M, et al: Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur Respir J 1997;10:1405-7.
13. Kudoh Y, Kuroda S, Shimamoto K, et al: Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol 1997;48:41-3.
14. Saeki T, Miyamura S, Nakano M, et al: A case of Grave's disease with MPO-ANCA-associated glomerulonephritis during propylthiouracil (PTU) therapy following interstitial pneumonitis [in Japanese; English abstract]. Nippon Jinzo Gakkai Shi 1997; 39:167-71.
15. Miller RM, Savige J, Nassis L, et al: Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Grave's disease. Australas J Dermatol 1998;36:96-9.
16. Pillinger M, Staud R: Wegener's granulomatosis in a patient receiving propylthiouracil for Grave's disease. Semin Arthritis Rheum 1998;28:124-9.
17. Kawasaki Y, Suzuki J, Sike T, et al: A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Grave's disease [in Japanese; English Abstract]. Nippon Jinzo Gakkai Shi 1998;40:612-7.
18. Gunton JE, Stiel J, Caterson RJ, et al: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999; 84:13-6.
19. Morita S, Ueda Y, Eguchi K: Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature. Endocr J 2000;47:467-70.
20. Wang LH, Tsai MJ, Tsai WY, et al: propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis - a case report. J Formos Med Assoc 2000; 99:642-5.
21. Colakovski H, Lorber DL: Propylthiouracil-induced perinuclear-staining antineutrophil cytoplasmic autoantibody-positive vasculitis in conjunction with pericarditis. Endocr Pract 2001;7:37-9.
22. Katayama K, Hata C, Kagawa K, et al: Diffuse alveolar hemorrhage associated with myeloperoxidase-antineutrophil cytoplasmic antibody induced by propylthiouracil therapy. Respiration 2002;69:473.
23. Winters MJ, Hurley RM, Lirenman DS: ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol 2002;17:257-60.
24. Kaaroud H, Khiari K, Ben Moussa F, et al: Vasculitis with renal and pulmonary involvement in a patient receiving benzylthiouracil for Grave's disease. Rev Med Interne 2002;23:857-61.
25. Thong HY, Chu CY, Chiu HC: Methimazole-induced anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of veisculo-bullous systemic lupus erythematosus. Acta Derm Venereol 2002;82:206-8.
26. Xu X, Zhao M, Zhang Y, et al: Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review [in Chinese: English abstract]. Zhonghua Nei Ke Za Zhi 2002;41:404-7.
27. Sera N, Ashizawa K, Ando T, et al: Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Grave's disease. Thyroid 2000;10:595-9.
28. Gunton JE, Stiel J, Clifton-Bligh P, et al|: Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol 2000;142:587-90.
29. Wada N, Mukai M, Kohno M, et al: Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Grave's disease treated with propylthiouracil and thiamazole. Endocr J 2002;49:329-34.
30. Sato H, Hattori M, Fujieda M, et al: High prevalence of anti-neutrophil cytoplasmic antibody positivity in childhood onset Grave's disease treated with propylthiouracil. J Clin Endocrinol Metab 2000;85:4270-3.
31. Noh JY, Asari T, Hamada N, et al: Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Grave's disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf) 2001;54:651-4.
32. Wu YY, Hsu CT, Chen TY, et al: Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 2002;128:347-52.
33. Freire BA, Paula ID, Paula F, et al: Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases. Am J Med Sci 2001; 321:109-12.
34. Takahashi A, Tamura A, Ishikawa O: Antiphopholipid antibody syndrome complicated by Grave's diseases. J Dermatol 2002;29: 776-80.
35. Ligier S, Pham CD, Kevin Watters A, et al: Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease. Scand J Rheumatol 2002;31:371-3.
36. Inamo Y, Harada K: Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease. J Rheumatol 1997; 24:576-8.
37. Baethge BA, Levine SN, Wolf RE: Antibodies to nuclear antigens in Grave's disease. J Clin Endocrinol Metab 1988;66:485-8.
38. Waldhauser L, Uetrech J: Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cats. Toxicology 1996;144:155-62.